2005-2021年中国引发公众关注的疫苗事件及相关的免疫规划政策与实践变化
研究梳理2005至2021年中国中央政府调查回应的7起疫苗事件,每起引发超10万条媒体报道,极少儿童直接受疫苗伤害。政府均以项目或政策调整回应,最根本为2019年《疫苗管理法》出台,多数事件后疫苗信心与覆盖率出现暂时下降。
要点
- 7起疫苗事件均引发全国或国际超10万条主流或社交媒体报道。
- 政府回应包括调整免疫活动、学校接种场所、非规划疫苗经济激励、采购分发及政策制定。
核心结论
- 7起事件均引发大量国内外主流与社交媒体批评讨论,多表达对疫苗安全性或有效性的担忧。
- 多数事件后疫苗信心与覆盖率出现时间相关的暂时下降,威胁数十年免疫工作成果。
- 中央政府通过解决根本原因回应每起事件,忠实实施《疫苗管理法》对强化规划及维持各方信心至关重要。
研究设计与样本
- 研究纳入2005年以来由中国中央政府调查回应的所有疫苗事件。
- 通过互联网搜索核实事件在主流与社交媒体上的可见度。
- 从政府会议官方报告及含媒体简报的官方网站提取事件时间、原因、调查过程、结果、行动及政策或实践法规变化。
主要发现
- 识别出7起疫苗事件,每起造成全国或国内外超10万条主流或社交媒体报道。
- 事件中极少儿童直接受到疫苗伤害。
- 政府以项目或政策变化回应每起事件,其中一起以立法回应。
- 回应影响免疫活动与补充免疫活动开展、学校作为接种场所、接种非规划疫苗的经济激励、疫苗采购分发及规划政策制定。
关键数值与推荐
- 最根本的回应是颁布该国首部疫苗法,即2019年《疫苗管理法》,指导从疫苗研发到监管、项目实施及安全与影响监测的几乎所有方面。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Several vaccine events causing public concern have occurred in China that were investigated and responded to by the central government. We describe causes, influences, and policy or practice changes associated with vaccine events that occurred between 2005 and 2021. We make recommendations to foster resilience in China's Expanded Program of Immunization (EPI) system and vaccination enterprises and to sustain vaccine and program confidence. METHODS: Our study included all vaccine events since 2005 that were investigated and responded to by the central government of China. We verified mainstream and social media visibility of the events through Internet search. We extracted event times, causes, investigation processes, results, actions, and policy or practice regulation changes from official reports of government meetings and from official websites with media briefings. RESULTS: Seven vaccine events were identified, each of which caused more than 100,000 mainstream or social media reports nationally or nationally and internationally. The events ranged in magnitude from 145 children receiving out-of-date oral poliovirus vaccine to a measles supplementary immunization activity involving 103 million children. Few, if any, children were directly harmed by vaccines in the events. Government responded to each event with program or policy changes, and in one case, with legislation. Responses affected the conduct of campaigns and supplementary immunization activities, use of schools as vaccination venues, financial incentives for vaccinating with non-program vaccines, vaccine procurement and distribution, and program policy making. The most fundamental response was enacting the country's first vaccine law, the 2019 Vaccine Administration Law, which guides virtually all aspects of vaccination work, from vaccine development through regulation, program implementation, and safety and impact monitoring. CONCLUSIONS: All seven events generated substantial national and international mainstream and social media criticism and discussion, most commonly expressed through concerns of vaccine safety or vaccine effectiveness. Most had temporally associated temporary declines in vaccine confidence and coverage, jeopardizing decades of vaccination effort. The central government responded to each event by attempting to address root causes. Faithful implementation of the Vaccine Administration Law is fundamental to program strengthening and sustaining confidence of families, stakeholders, and government in vaccines and immunization in China.
引用
- Liu X, Yu W, Yin Z, et al. Vaccine events raising public concern and associated immunization program policy and practice changes, China, 2005-2021. Vaccine. 2022. PMID: 35339307. doi:10.1016/j.vaccine.2022.03.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。